U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06955650) titled 'First-in-man Imaging of a New PET Radiotracer for Oxytocin Receptors' on Aug. 10, 2022.
Brief Summary: The investigators will test a new positron-emitting radiotracer to determine whether it is suitable for studying the oxytocin receptor by positron emission tomography (PET) in humans. If suitable, the radiotracer will be used to study the brain and trigeminal nerve in several disorders.
Study Start Date: April 30, 2021
Study Type: INTERVENTIONAL
Condition:
Pain, Face
Intervention:
DRUG: Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor
13N-Oxytocin is a newly devel...